Trident Texofab Ltd
company logo

Trident Texofab Ltd

Trident Texofab Share Price

Trading
Small Cap

-

0 (0%)

Start Investing in Trident Texofab Ltd

*By signing up you agree to our Terms and Conditions

Trident Texofab Ltd Performance

-

-

-

-


-

-

-

-

-

Trident Texofab Ltd Fundamentals

47.83Cr

25.68

2.94

2.48

1.85

0%

16.14

i buttonClick here to know more about Fundamentals

Trident Texofab Ltd Financials

Trident Texofab Ltd Financialsright-arrow

Trident Texofab Ltd Shareholding Pattern

Trident Texofab Ltd Delivery and Volume

About Trident Texofab Ltd

Trident Texofab Limited was originally incorporated as a Private Limited Company with the name 'Trident Texofab Private Limited' on September 05, 2008. Subsequently, the Company was converted into Public Limited Company and the name of the company was changed to 'Trident Texofab Limited' on June 06,

Hardik J Desai

2008

-

NameDesignation
Hardik J DesaiChairman & Managing Director
Chetan C JariwalaWhole-time Director
Natasha F DsouzaIndependent Director
Ankita Jignesh SaraiyaIndependent Director
Deepak P GandhiDirector
Vrusti B PatelAddtnl Independent Director
Manish Dhirajlaa HalwawalaDirector
Rushi Hemantkumar JaganiDirector
Mishal Shailesh PatelAdditional Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Trident Texofab Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Trident Texofab Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Trident Texofab Ltd's share price is ₹46.88 as of 2024-09-19.
Trident Texofab Ltd's P/E ratio is 25.68 times as of 2024-09-19.
Trident Texofab Ltd's most recent financial reports indicate a price-to-book ratio of 2.94, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Trident Texofab Ltd's market capitalization is ₹47.83 Cr as on 2024-09-19.
The current financial records of Trident Texofab Ltd show a 5.47% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Trident Texofab Ltd's most recent financial filings, the company has a total asset value of ₹52.1, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Trident Texofab Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Trident Texofab Ltd's 52-week high and low as of 2024-09-19 are ₹49 and ₹46.3, respectively.